Relevance to NICE guidance programmes
This use of rifaximin is not appropriate for referral for a NICE technology appraisal and is not currently planned into any other work programme.
NICE has issued clinical guidelines on conditions that may be associated with surgical construction of an ileoanal pouch:
Ulcerative colitis: management in adults, children and young people (NICE clinical guideline 166)
Colorectal cancer: the diagnosis and management of colorectal cancer (NICE clinical guideline 131).
NICE guidance is in development for a licensed indication for rifaximin:
Rifaximin for the maintenance treatment of hepatic encephalopathy (NICE technology appraisal guidance, publication date to be confirmed).